title: What Is the Clinical Value Associated with Defining Additional Disease-Specific 'Prognostic Indicators'?
authors.forename: Maurie
authors.initials: M
authors.lastname: Markman
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000737:chemistry*; D010051:Ovarian Neoplasms / Q000737:chemistry* / Q000473:pathology*; D010455:Peptides / Q000032:analysis*; D051736:Proto-Oncogene Proteins c-mdm2 / Q000032:analysis*; D013223:Statistics as Topic; D016159:Tumor Suppressor Protein p53 / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D010455:Peptides; D016159:Tumor Suppressor Protein p53; D051736:Proto-Oncogene Proteins c-mdm2